MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS

Inhibitors of HCV replication of formula (I) and the N-oxides, salts, and stereoisomers thereof, wherein each variable has specific definitions. Pharmaceutical compositions containing compounds (I) and process for preparing compounds (I) are also provided. Bioavailable combinations of the inhibitors...

Full description

Saved in:
Bibliographic Details
Main Authors RABOISSON, PIERRE JEAN-MARIE BERNARD, DE KOCK, HERMAN AUGUSTINUS, WALLBERG, HANS KRISTIAN, TAHRI, ABDELLAH, SAMUELSSON, BENGT BERTIL, VAN DE VREKEN, WIM, HU, LILI, ROSENQUIST, ÅSA ANNICA KRISTINA, SIMONNET, YVAN, DORANGE, ISMET, VENDEVILLE, SANDRINE MARIE HELENE, SIMMEN, KENNETH ALAN, NILSSON, KARL MAGNUS, SURLERAUX, DOMINIQUE LOUIS NESTOR GHISLAIN
Format Patent
LanguageEnglish
Polish
Published 30.06.2014
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Inhibitors of HCV replication of formula (I) and the N-oxides, salts, and stereoisomers thereof, wherein each variable has specific definitions. Pharmaceutical compositions containing compounds (I) and process for preparing compounds (I) are also provided. Bioavailable combinations of the inhibitors of HCV of Formula (I) with ritonavir are also provided.
Bibliography:Application Number: PL20060778068T